Intelligence Diagnostic Market – Market Forecast & Trends
Global Artificial Intelligence Diagnostic Market was assessed at USD 288.1
million in 2019 and is expected to reach USD 2043.91 million by 2026, at a CAGR
of 32.3% during the prediction period. Growing demands for reduced diagnostic costs, improved patient care,
and shortened machine downtime are the factors that accelerated the usage of
artificial intelligence in diagnostics. Besides, growing requests for low-cost
diagnostic methods, actual and competent report testing and quick diagnostic
data generation are some other factors contributing to the growth of AI in
With the growth of deep
learning and neural networks, artificial intelligence (AI) has gained learning
competencies resulting in better detection of the useful patterns by AI than human
eyes. It paves the way for the emergence of a new age of medical diagnosis
devices proficient than best medical professionals. As artificial intelligence
can imagine, the advantage of this proficiency can be availed by a significant
number of patients. Moreover, increasing strategic alliances and collaborations
among diverse AI solution providers and health facilities favorably affects
Intelligence Diagnostic Market – Overview
(AI) refers to forming unique systems with the help of procedures and software
that can accomplish specific tasks without human interference and commands.
Artificial intelligence implies incorporating several technologies such as
machine learning, natural language processing, reasoning, and insight. It is
used in healthcare to approximate human perception and to infer findings of
complicated medical and diagnostic data presented in graphs or other images.
Artificial intelligence is mainly used in healthcare to find the relationship
between treatment techniques and effects on the patient.
AI programs are deployed
in medical practices such as diagnostic procedures, drug growth, personalized
medicines, and patient testing care. For instance, AI helps in clinical procedures
by checking the vital signs, asking questions, and giving patients
prescriptions. AI systems can also be used for warnings and reminders, image
interpretation, information retrieval, and designing a treatment plan during
medical procedures. Deep learning technology is used for image identification,
signal recognition, and data removal and is the most extensively used form of
Alliances and Collaborations among Several AI Solution Providers and Healthcare
alliances and collaborations between numerous AI solution providers and
healthcare facilities is an additional factor enhancing market growth. For
instance, Boston based Partners HealthCare collaborated with FUJIFILM SonoSite,
Inc. in August 2019 for applying AI to transferrable ultrasound technology
useful for point-of-care testing. Under this partnership, the Partners
HealthCare's clinical expertise, datasets, and IT setup will be used with
FUJIFILM's portable ultrasound technology for developing AI-powered devices.
These devices are used in trauma medical procedures, reducing the downtime
between trauma and diagnosis, making fast interferences and health improvement
of patient possible.
Rise of advanced AI
The major factors pushing
the development of the Global Artificial Intelligence (AI) market are the
acceleration in the acceptance of cloud-based applications and services and the
growth of big data across the globe. The progressive AI technologies are incessantly
enhancing the performance of economies, businesses, and diverse industries. The
rising demand for intelligent virtual assistants over diverse verticals in
several industries will have an optimistic influence on the Global Artificial
Intelligence (AI) market during the prediction period. The expanded integration
of image recognition technology with optical character recognition, pattern
matching, and face recognition in various end-use devices such as drones,
self-driving cars, and robotics will promote the development of the artificial
intelligence market during the prediction period.
Intelligence Diagnostic Market: Segmentation
Software segment in the
AI healthcare market is estimated to register the highest CAGR during the prediction
period. Many companies are emerging with diverse software solutions for
multiple healthcare uses; this is a critical factor supplementing the software
segment's development. The growing acceptance of AI-driven healthcare
informatics solutions and healthcare operational support by hospitals and other
healthcare service providers is predicted to bring a surge in AI applications
in the latter part of the prediction period.
Machine learning in the
AI healthcare market is anticipated to exhibit the highest CAGR during the
prediction period. Rising acceptance of deep learning in numerous healthcare
uses, particularly in the areas of medical imaging, disease diagnosis, and drug
development is a major pushing factor for this market. Besides, the use of different
sensors and devices to present or monitor a patient's health status in
real-time also encourages the development of the market.
Medical imaging &
diagnostics section in the AI healthcare market is expected to grow at the
highest CAGR during the forecast period. The factors such as the existence of a
large volume of imaging data, the returns offered by AI systems to radiologists
in analysis and cure management, and the influx of a large number of startups
contribute to the substantial development of medical imaging and diagnostics in
Patients section in the
AI healthcare market is also predicted to grow at the highest CAGR during the
predicted period. Growing demand for modified care, the need to reduce hospital
readmissions, and the suitability and answers offered by AI products are the
key elements driving the development of the patient's section in the AI in the
Based on the region,
Global Artificial Intelligence Diagnostic Market is segmented into five
regions— North America, Europe, Asia Pacific, South America, and the Middle
East & Africa.
Intelligence Diagnostic Market: Regional Insights
The Asia Pacific is
predicted to be the most profitable region with a substantial growth rate
during the forecast period. The government has undertaken various initiatives
for the adoption of AI-based diagnostic technologies by healthcare providers
and other healthcare organizations. Besides, the increased savings by nonprofit
organizations and private companies with better information exchange and
improved clinical outcomes are pushing the market growth.
Cost reduction is the
primary concern anticipated to drive the development of the market for AI in
diagnostics in the Asia Pacific during the prediction period. Moreover, high
requests for e-diagnostic services in the healthcare segment because of
increased government outlay on healthcare contribute to market development in
the Asia Pacific. China allots the highest outlay to the healthcare sector
among APAC countries and has drawn official plans to digitize medical records.
Besides, the Chinese government is undertaking initiatives to stimulate the
acceptance of AI technologies in healthcare. All such developments are likely
to grow AI use in robust healthcare diagnostics in the most populated country
China. Japan is likely to capture the second-largest market share during the
companies in this market are IBM Corporation, Google, Inc., NVIDIA Corporation,
Microsoft Corporation, iCarbonX, Next IT Corp., CloudMex Inc., Carescore,
Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., Medtronic Plc.,
Koninklijke Philips N.V., and Oncora Medical, Inc. and others.
In 2016, Google allied
with the U.K.'s NHS to analyze medical images collected from patients for early
· In 2017, Nvidia
Corporation collaborated with GE Healthcare to speed up the adoption of AI in
healthcare. As per the agreement, Nvidia Corporation is expected to integrate
its artificial intelligence (AI) with 500,000 imaging devices of GE Healthcare
Scope of the Report
data – 2016-2019
Base Year –
2020 – 2026
Revenue in USD Million
Canada, Germany, UK, France, Italy, Spain, Japan, China, India and others
By Solution, By Technology, By Application, By End-User, By
Corporation, Google, Inc., NVIDIA Corporation, Microsoft Corporation,
iCarbonX, Next IT Corp., CloudMex Inc., Carescore, Atomwise Inc., Zephyr
Health Inc., Deep Genomics Inc., Medtronic Plc., Koninklijke Philips N.V.,
and Oncora Medical, Inc. and others.
Ø Software & Services
Ø Speech Recognition
Ø Querying Method
Ø Natural Language Processing
Ø Machine Learning
Ø Context-Aware Processing
Ø Imaging & Diagnostics
Ø Drug Discovery
Ø Lifestyle Management & Monitoring
Ø Emergency Room & Hospital Management
Ø Insights & Risk Analytics
Ø Virtual Assistants
Ø Pharmaceutical Organizations
Ø Diagnostic Centers
Ø North America
Ø Asia Pacific
Ø South America
Ø Middle East & Africa
The objective of the Study:
Ø To analyze and estimate the Global Artificial Intelligence
Diagnostic market size, in terms of value.
Ø To examine the market segmentation carefully and estimate the
market size, in terms of value, based on the region by segmenting the Global
Dry Ice market into five regions, namely, North America, Europe, Asia Pacific,
Rest of the World and their leading countries.
Ø To outline, categorize and project the Global Artificial
Intelligence Diagnostic market based on the Type and Application.
Ø To study competitive developments like technological advancement,
services, and regulatory framework within the Global Artificial Intelligence
Ø To highlight market dynamics such as drivers, restraints,
opportunities, and challenges and their impact.
Ø To provide a detailed competitive landscape, including major
players, strategic profiles, and market shares.
Business Questions Answered by the Report
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis